UK's Medicines and Healthcare products regulatory agency issued the advisory after two NHS workers developed allergies shortly after receiving the Pfizer vaccine; they're stable now.
World News/Covid-19 Vaccine Tracker: British healthcare regulator has issued a warning that individuals with history of serious allergies shouldn't be given the newly approved Pfizer-BioNTech COVID-19 vaccine. The advisory was issued after two NHS workers suffered allergic reactions on Tuesday.
Medicines and Healthcare products regulatory agency (MHRA) said that the allergy advisory applies to people that have had reactions to medicines, food or vaccines, reported the BBC.
Dr June Raine, chief executive of MHRA, informed a parliamentary committee on Wednesday that the cases of severe allergic reactions didn't appear during vaccine trials. "We know from the very extensive clinical trials that this wasn't a feature. But if we need to strengthen our advice, now that we've had this experience in the vulnerable populations - the groups have been selected as a priority - we get that advice to the field immediately," said Dr Raine.
Also Read| British Grandma Is 1st In World To Get Pfizer Covid-19 Vaccine Outside Trial
The two UK healthcare workers reportedly developed anaphylactoid reaction shortly after the Pfizer COVID-19 vaccine was administered to them, the report said. They received treatment shortly after, and are stable now.
Also Read| Pfizer wants approval for emergency use in India after UK
Anaphylactoid reactios appear as skin rashes, breathlessnes and a drop in blood pressure. this is often different from anaphylaxis, which may cause death.
Notably, both individuals have prior history of allergies and carried adernaline pens for fiirst aid within the event of severe reactions.
The Pfizer-BioNTech jab, codenamed BNT162b2, became the first ever vacccine against coronavirus to receive emergency use approval - first in the UK then in Bahrain. the companies have also approved regulators in India for emergency use authorisation of the inoculation, but it seems like a long shot, considering the very fact it's never underwent any trials within the country. The vaccine has got to be stored at extremely frigid temperatures of -70 degree Centigrade , which presents another argument against its appoval by the Indian regulator.
Also Read| UK approved Pfizer-BioNtech's COVID-19 vaccine, Vaccination starting from next week
Meanwhile, the united kingdom has began to vaccinate its priority groups against COVID-19 using the Pfizer vaccine. Margaret Keenan, 90, and Shakespeare , 81, were the first and second recipients of the jab vaccine in the world. British government intends to administer 800,000 in the coming weeks.
No comments:
Post a Comment